| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.2 |